Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model

Stem cell treatment may enhance erectile dysfunction (ED) in individuals with cavernous nerve injury (CNI). Nevertheless, no investigations have directly ascertained the implications of varying amounts of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) on ED. We compare the efficacy o...

Full description

Saved in:
Bibliographic Details
Main Authors: Wei Wang, Ying Liu, Zi-Hao Zhou, Kun Pang, Jing-Kai Wang, Peng-Fei Huan, Jing-Ru Lu, Tao Zhu, Zuo-Bin Zhu, Cong-Hui Han
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2025-07-01
Series:Asian Journal of Andrology
Subjects:
Online Access:https://journals.lww.com/10.4103/aja2024115
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839640390946258944
author Wei Wang
Ying Liu
Zi-Hao Zhou
Kun Pang
Jing-Kai Wang
Peng-Fei Huan
Jing-Ru Lu
Tao Zhu
Zuo-Bin Zhu
Cong-Hui Han
author_facet Wei Wang
Ying Liu
Zi-Hao Zhou
Kun Pang
Jing-Kai Wang
Peng-Fei Huan
Jing-Ru Lu
Tao Zhu
Zuo-Bin Zhu
Cong-Hui Han
author_sort Wei Wang
collection DOAJ
description Stem cell treatment may enhance erectile dysfunction (ED) in individuals with cavernous nerve injury (CNI). Nevertheless, no investigations have directly ascertained the implications of varying amounts of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) on ED. We compare the efficacy of three various doses of HUC-MSCs as a therapeutic strategy for ED. Sprague–Dawley rats (total = 175) were randomly allocated into five groups. A total of 35 rats underwent sham surgery and 140 rats endured bilateral CNI and were treated with vehicles or doses of HUC-MSCs (1 × 106 cells, 5 × 106 cells, and 1 × 10 7 cells in 0.1 ml, respectively). Penile tissues were harvested for histological analysis on 1 day, 3 days, 7 days, 14 days, 28 days, 60 days, and 90 days postsurgery. It was found that varying dosages of HUC-MSCs enhanced the erectile function of rats with bilateral CNI and ED. Moreover, there was no significant disparity in the effectiveness of various dosages of HUC-MSCs. However, the expression of endothelial markers (rat endothelial cell antigen-1 [RECA-1] and endothelial nitric oxide synthase [eNOS]), smooth muscle markers (alpha smooth muscle actin [α-SMA] and desmin), and neural markers (neurofilament [RECA-1] and neurogenic nitric oxide synthase [nNOS]) increased significantly with prolonged treatment time. Masson’s staining demonstrated an increased in the smooth muscle cell (SMC)/collagen ratio. Significant changes were detected in the microstructures of various types of cells. In vivo imaging system (IVIS) analysis showed that at the 1st day, the HUC-MSCs implanted moved to the site of damage. Additionally, the oxidative stress levels were dramatically reduced in the penises of rats administered with HUC-MSCs.
format Article
id doaj-art-3fbee05f9f8146c8ab5b65f90d7ce5d3
institution Matheson Library
issn 1008-682X
1745-7262
language English
publishDate 2025-07-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Asian Journal of Andrology
spelling doaj-art-3fbee05f9f8146c8ab5b65f90d7ce5d32025-07-03T14:52:25ZengWolters Kluwer Medknow PublicationsAsian Journal of Andrology1008-682X1745-72622025-07-0127450851510.4103/aja2024115Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat modelWei WangYing LiuZi-Hao ZhouKun PangJing-Kai WangPeng-Fei HuanJing-Ru LuTao ZhuZuo-Bin ZhuCong-Hui HanStem cell treatment may enhance erectile dysfunction (ED) in individuals with cavernous nerve injury (CNI). Nevertheless, no investigations have directly ascertained the implications of varying amounts of human umbilical cord-derived mesenchymal stem cells (HUC-MSCs) on ED. We compare the efficacy of three various doses of HUC-MSCs as a therapeutic strategy for ED. Sprague–Dawley rats (total = 175) were randomly allocated into five groups. A total of 35 rats underwent sham surgery and 140 rats endured bilateral CNI and were treated with vehicles or doses of HUC-MSCs (1 × 106 cells, 5 × 106 cells, and 1 × 10 7 cells in 0.1 ml, respectively). Penile tissues were harvested for histological analysis on 1 day, 3 days, 7 days, 14 days, 28 days, 60 days, and 90 days postsurgery. It was found that varying dosages of HUC-MSCs enhanced the erectile function of rats with bilateral CNI and ED. Moreover, there was no significant disparity in the effectiveness of various dosages of HUC-MSCs. However, the expression of endothelial markers (rat endothelial cell antigen-1 [RECA-1] and endothelial nitric oxide synthase [eNOS]), smooth muscle markers (alpha smooth muscle actin [α-SMA] and desmin), and neural markers (neurofilament [RECA-1] and neurogenic nitric oxide synthase [nNOS]) increased significantly with prolonged treatment time. Masson’s staining demonstrated an increased in the smooth muscle cell (SMC)/collagen ratio. Significant changes were detected in the microstructures of various types of cells. In vivo imaging system (IVIS) analysis showed that at the 1st day, the HUC-MSCs implanted moved to the site of damage. Additionally, the oxidative stress levels were dramatically reduced in the penises of rats administered with HUC-MSCs.https://journals.lww.com/10.4103/aja2024115cavernous nerve injurydoseserectile dysfunctionhuman umbilical cord-derived mesenchymal stem cells
spellingShingle Wei Wang
Ying Liu
Zi-Hao Zhou
Kun Pang
Jing-Kai Wang
Peng-Fei Huan
Jing-Ru Lu
Tao Zhu
Zuo-Bin Zhu
Cong-Hui Han
Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
Asian Journal of Andrology
cavernous nerve injury
doses
erectile dysfunction
human umbilical cord-derived mesenchymal stem cells
title Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
title_full Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
title_fullStr Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
title_full_unstemmed Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
title_short Effects of human umbilical cord-derived mesenchymal stem cell therapy for cavernous nerve injury-induced erectile dysfunction in the rat model
title_sort effects of human umbilical cord derived mesenchymal stem cell therapy for cavernous nerve injury induced erectile dysfunction in the rat model
topic cavernous nerve injury
doses
erectile dysfunction
human umbilical cord-derived mesenchymal stem cells
url https://journals.lww.com/10.4103/aja2024115
work_keys_str_mv AT weiwang effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT yingliu effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT zihaozhou effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT kunpang effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT jingkaiwang effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT pengfeihuan effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT jingrulu effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT taozhu effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT zuobinzhu effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel
AT conghuihan effectsofhumanumbilicalcordderivedmesenchymalstemcelltherapyforcavernousnerveinjuryinducederectiledysfunctionintheratmodel